Author(s): McRae AT rd, Chung MK, Asher CR
Abstract Share this page
Abstract Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an increasingly recognized cause of ventricular tachycardia and sudden cardiac death in young people, notably young athletes. The best treatment is not clear, although options include antiarrhythmic drugs, radiofrequency ablation, and implantable defibrillators.
This article was published in Cleve Clin J Med
and referenced in Journal of Clinical & Experimental Cardiology